Characterization of Unintentional Deaths Among Buprenorphine Users

Original research
par
Dai, Zhen et al

Date de publication

2023

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

This study sought to examine buprenorphine-involved deaths (BIDs) and compare them with other drug-related deaths.

Constatations/points à retenir

Despite increasing buprenorphine use, BIDs comprised less than 5% of overall West Virginia drug-related deaths. Seldom was it the only drug found, and most decedents did not have current prescriptions for buprenorphine. Although buprenorphine is effective, with a wide safety margin, clinicians and patients should be aware that buprenorphine can be involved in overdose deaths, especially when buprenorphine is taken in combination with drugs such as benzodiazepines, methamphetamine, or fentanyl, and in persons with underlying cardiovascular or pulmonary comorbidities.

La conception ou méthodologie de recherche

Analyzed West Virginia drug-related deaths from 2005 to early 2020 (11,764)

Mots clés

Substitution/OAT
Mortality